文献速递主动脉疾病

腹主动脉瘤腔内修复术支架器械研发试验中按性别和种族/民族招募与结局报告的系统综述

A Systematic Review of the Recruitment and Outcome Reporting by Sex and Race/Ethnicity in Stent Device Development Trials for Endovascular Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2022-10-19

该系统综述检索MEDLINE、PubMed、Embase和ClinicalTrials.gov至2022年1月,纳入55项由工业资助的腹主动脉瘤腔内修复术(EVAR)支架器械研发试验。结果显示93%的试验报告了性别招募情况,仅13%报告了种族/民族招募情况,女性参与者与男性参与者的中位数分别为19例与171例,无任何试验按性别或种族/民族报告结局。

要点

  • 55项工业资助EVAR器械试验中,93%报告性别招募,仅13%报告种族/民族招募。
  • 女性参与者中位数19例远低于男性171例,种族/少数族裔参与者中位数17例远低于白人241例。
  • 女性占疾病人群16.6%,中位参与-患病比(PPR)为0.62(IQR:0.42, 0.88),随时间保持恒定。

核心结论

  • 该系统综述突显了EVAR器械研发试验中按性别和种族/民族在招募与结局报告方面的差异。

研究设计与样本

  • 系统综述,检索MEDLINE、PubMed、Embase和ClinicalTrials.gov从建库至2022年1月,无语言限制。
  • 纳入所有I-III期及上市后评估试验,患者≥18岁且接受EVAR,共55项工业资助试验符合纳入标准。
  • 由两名独立评审员筛选和提取数据,计算参与-患病比(PPR)以评估试验参与者按性别和种族/民族的代表性。

主要发现

  • 在4780篇检索文章中,55项工业资助试验符合纳入标准。
  • 51项试验(93%)报告了按性别/性别的招募情况,仅7项试验(13%)报告了按种族/民族的招募情况。
  • 女性参与者中位数19例(IQR:4.5, 51),男性参与者中位数171例(IQR:57, 311.5)。
  • 种族/少数族裔患者中位数17例(IQR:7.5, 21.5),白人参与者中位数241例(IQR:123, 463.5)。
  • 女性占疾病人群16.6%,中位PPR为0.62(IQR:0.42, 0.88),随时间保持恒定;无任何器械试验按性别/性别或种族/民族报告结局。

局限性

  • 大多数试验可能不足以检验这些差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women and racial/ethnic minority groups have been shown to experience poor outcomes after endovascular aortic aneurysm repair (EVAR). One potential reason is the rare inclusion of these populations in initial phases of device development. The objective of this systematic review is to understand enrollment and outcome reporting by sex and race/ethnicity in industry-funded EVAR device development trials. METHODS: MEDLINE, PubMed, and Embase were searched from inception to January 2022 without language restrictions using the following terminology: "stent", "graft", "endograft", "device", and "abdominal aortic aneurysm" (AAA). CLINICALTRIALS: gov was also searched from inception to January 2022 for "AAA." Two independent reviewers screened and extracted data. All phase I-III and postmarket evaluation trials that included patients ≥18 years of age, who underwent EVAR were assessed. Participation-to-prevalence ratios (PPRs) were calculated to estimate representation of participants by sex and race/ethnicity in trials compared with their share of disease burden. RESULTS: Among the 4,780 retrieved articles, 55 industry-funded trials met inclusion criteria for this review. A total of 51 trials (93%) reported enrollment by sex/gender, and only 7 trials (13%) reported enrollment by race/ethnicity of the participants. A median of 19 (interquartile range [IQR]: 4.5, 51) women participants were recruited compared to 171 (IQR: 57, 311.5) men, and 17 (IQR: 7.5, 21.5) racial/minority patients were recruited compared to 241 (IQR: 123, 463.5) White participants. Women represent 16.6% of the disease population, and the median PPR is 0.62 (IQR: 0.42, 0.88), which has remained constant over time (Figure 1). None of the device trials reported outcomes based on sex/gender or race/ethnicity. CONCLUSIONS: This systematic review highlights the disparities in recruitment and outcome reporting based on sex and race/ethnicity in EVAR device development trials. While most trials may be underpowered to study these differences, recent registry studies show differential outcomes based on sex and race/ethnicity of vascular patients. Therefore, it is imperative to include and report outcomes in these participants, starting from the initial device development phases to improve generalizability of device-use and understand sources of variation in device performance.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel J, Pallapothu S, Langston A, et al. A Systematic Review of the Recruitment and Outcome Reporting by Sex and Race/Ethnicity in Stent Device Development Trials for Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2022. PMID: 36272665. doi:10.1016/j.avsg.2022.09.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。